- Trials with a EudraCT protocol (229)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
229 result(s) found for: Dilatation.
Displaying page 1 of 12.
EudraCT Number: 2012-003252-37 | Sponsor Protocol Number: OXYDILAT | Start Date*: 2012-10-08 | |||||||||||
Sponsor Name:Aarhus University Hospital, Department of Ophthalmology | |||||||||||||
Full Title: The effect of topical anaesthesia on pharmacological mydriasis in patients screened for diabetic retinopathy | |||||||||||||
Medical condition: Diabetic retinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003287-25 | Sponsor Protocol Number: 2018-002863-24,2022-003287-25 | Start Date*: 2023-04-10 |
Sponsor Name:Erasmus University Medical Center - Sophia Childrens Hospital | ||
Full Title: Intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia - a randomized controlled trial | ||
Medical condition: Recurrent anastomotic strictures in the esophagus following surgical repair with primary anastomosis of esophageal atresia in neonates. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002863-24 | Sponsor Protocol Number: 65364 | Start Date*: 2019-01-11 |
Sponsor Name:Erasmus MC | ||
Full Title: Intralesional steroid injections to prevent refractory strictures in patinets with esophageal atresia - a randomized controlled trial | ||
Medical condition: Recurrent stenosis after correction of esophageal atresia | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) FI (Trial now transitioned) FR (Trial now transitioned) DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005856-33 | Sponsor Protocol Number: AT10008 | Start Date*: 2007-02-13 | |||||||||||
Sponsor Name:The Department of Molecular Medicin and Surgery, P9:03, Karolinska Institutet | |||||||||||||
Full Title: Local Glucocorticoid Injektion in the Treatment of Benign Oesophageal Strictures, a Randomized Clinical Study | |||||||||||||
Medical condition: Patients with benign oesophageal strictures and symptoms where dilatation of the stricture is planned. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001201-28 | Sponsor Protocol Number: 2006-02-27UUS | Start Date*: Information not available in EudraCT |
Sponsor Name:Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest | ||
Full Title: Self-administered vaginal misoprostol at home for cervical ripening prior to outpatient hysteroscopy: a randomised placebo-controlled trial. | ||
Medical condition: Intrauterine pathology | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019302-16 | Sponsor Protocol Number: 2010GU001B | Start Date*: 2010-09-13 |
Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust | ||
Full Title: A prospective, randomised, placebo-controlled, double blind, multi-centre study of the effects of Irbesartan on aortic dilatation in Marfan syndrome | ||
Medical condition: Marfan Syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006112-30 | Sponsor Protocol Number: P060210 | Start Date*: 2008-07-09 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude multicentrique, randomisée, en double aveugle, évaluant l'efficacité du losartan versus placebo sur la dilatation de l'aorte chez des patients présentant un syndrome de Marfan | |||||||||||||
Medical condition: Patients présentant un syndrome de Marfan traités par des béta bloquants | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001125-97 | Sponsor Protocol Number: LO-AT-MARFAN | Start Date*: 2008-05-20 | |||||||||||
Sponsor Name:alberto forteza | |||||||||||||
Full Title: Eficacia y Seguridad de Losartán vs Atenolol en la prevención de la dilatación progresiva de la aorta en la población de pacientes con Síndrome de Marfan (Losartan vs atenolol efficacy and security... | |||||||||||||
Medical condition: The aortic dilatation in Marfan syndrome with two different treatments: losartan vs atenolol | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000614-37 | Sponsor Protocol Number: 21467 | Start Date*: 2019-05-02 |
Sponsor Name:Region Örebro Län | ||
Full Title: Kort-SGS: Does a series of intralesional steroid injections after endoscopic treatments for subglottic stenosis prolong interval between between surgical interbentions? A prospective single blinded... | ||
Medical condition: Subglottic stenosis: Idiopatic, autoimmune, traumatic. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001723-12 | Sponsor Protocol Number: CSAI | Start Date*: 2013-10-07 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: A randomized, double-blinded, placebo-controlled study on the effects of adalimumab intralesional intestinal strictures of Crohn's disease patients | |||||||||||||
Medical condition: Crohn disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017622-39 | Sponsor Protocol Number: ERNLPT01 | Start Date*: 2010-04-21 |
Sponsor Name:Clinical Center Ljubljana | ||
Full Title: A double blind, randomized study to compare influence of niacin/laropiprant on functional and morphological characteristics of arterial wall and parameters of inflammation in subjects with CHD alre... | ||
Medical condition: To evaluate the influence of 12 weeks of ER niacin/laropiprant therapy on endothelial dependent dilatation of the arterial wall in CHD patients already treated with a statin compared to placebo as... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019591-67 | Sponsor Protocol Number: 1008032 | Start Date*: 2010-06-01 | |||||||||||
Sponsor Name:CHU de SAINT-ETIENNE | |||||||||||||
Full Title: Pain assessment during general anesthesia : DOLANS Study | |||||||||||||
Medical condition: perioperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009869-34 | Sponsor Protocol Number: BAYq3939/12965 | Start Date*: 2009-06-08 | ||||||||||||||||
Sponsor Name:Bayer HealthCare AG | ||||||||||||||||||
Full Title: Randomized, placebo-controlled, double-blind, multi center study to evaluate the safety and efficacy of ciprofloxacin inhale compared to placebo in patients with non-cystic fibrosis bronchiectasis | ||||||||||||||||||
Medical condition: Idiopathic and post-pneumonic non-Cystic Fibrosis Bronchiectasis in pulmonary stable patients (defined as FEV1 of > 35 % and < 80 percent of predicted) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) ES (Completed) SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-005839-20 | Sponsor Protocol Number: PPL02 | Start Date*: 2007-02-05 |
Sponsor Name:Dilafor AB | ||
Full Title: A randomised, double-blind, placebo-controlled, multicentre trial to access the safety and efficacy of pre-treatment with DF01 during late pregnancy in reducing prolonged labour. | ||
Medical condition: Pre-treatment during late pregnancy to reduce prolonged labour. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001530-32 | Sponsor Protocol Number: 200504012 | Start Date*: 2006-09-28 |
Sponsor Name:Jan Engvall | ||
Full Title: Can pharmacological stress test at MRI of the heart improve the detection of coronary stenoses/Kan belastningsprov i magnetkamera ge förbättrad diagnostik av kranskärlsförträngningar? | ||
Medical condition: Patients in the first week post myocardial infarction are referred for early coronary angiography. Often, balloon dilatation is performed at the time of angiography. It is debatable which stenose... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001071-30 | Sponsor Protocol Number: V1 | Start Date*: 2010-01-21 |
Sponsor Name:Medical University Vienna- Dept. of Pediatric Hemostaselology | ||
Full Title: Aspirin Resistance in Children after Interventional Cardiac Catheterization: The ARC Study | ||
Medical condition: children after interventional cardiac catheterization. | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003279-28 | Sponsor Protocol Number: LT2380-PII-11/07 | Start Date*: 2008-07-24 | |||||||||||||||||||||
Sponsor Name:Laboratoires Théa | |||||||||||||||||||||||
Full Title: Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaïne, phenylephrine and tropicamide) for anaesthesia and mydriasis in phacoemulsification cataract surgery | |||||||||||||||||||||||
Medical condition: The aim of the development was to develop a combination of active substances enabling to obtain at the same time a mydriasis and an anaesthesia during cataract surgery. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Ongoing) ES (Ongoing) BE (Ongoing) PT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002338-19 | Sponsor Protocol Number: BUSCLAB001 | Start Date*: 2019-01-22 |
Sponsor Name:Oslo University Hospital | ||
Full Title: BUSCLAB - A DOUBLE BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL INVESTIGATING THE EFFECT OF INTRAVENOUS BUTYLSCOPOLAMINE BROMIDE TO TREAT SLOW PROGRESS IN LABOR | ||
Medical condition: To study the effect of Butylscopolamide Bromide on duration of the active phase of first stage of labor in women who cross the alert-line for labor dystocia, according to the WHO partograph. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010842-67 | Sponsor Protocol Number: ATTICA 01/2009 | Start Date*: 2009-04-16 | ||||||||||||||||
Sponsor Name:OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO | ||||||||||||||||||
Full Title: Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI) | ||||||||||||||||||
Medical condition: candidates patients for percutaneous coronary intervention revascularization on the basis of claims made by the current guidelines in accordance with the criteria of inclusion / exclusion protocol | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000292-33 | Sponsor Protocol Number: HGC_SAR_1_13 | Start Date*: 2013-11-07 | ||||||||||||||||
Sponsor Name:Laura Sararols Ramsay | ||||||||||||||||||
Full Title: Comparative study of the mydriatic effect of Mydriasert vs the use of topical instillation of phenylephrine (10%) and tropicamide (1%) before catarcat surgery. | ||||||||||||||||||
Medical condition: Cataract surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.